Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Consolidated Statement of Profit and Loss and Other Comprehensive Loss

v3.22.1
Consolidated Statement of Profit and Loss and Other Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
[1]
Dec. 31, 2019
[1]
Profit or loss [abstract]      
Revenue from contracts with customers $ 322,921 $ 79,272 $ 16,034
Cost of care delivery (289,672) (67,254) (19,810)
Platform & application expenses (42,829) (38,137) (23,569)
Research & development expenses (47,534) (54,711) (51,205)
Sales, general & administrative expenses (196,673) (94,681) (84,270)
Recapitalization transaction expense (148,722) 0 0
Operating loss (402,509) (175,511) (162,820)
Finance costs (14,291) (4,530) (1,116)
Finance income 326 610 1,015
Change in fair value of warrant liabilities 27,811 0 0
Exchange gain / (loss) 868 (2,836) 17,075
Net finance income (expense) 14,714 (6,756) 16,974
Gain on sale of subsidiary 3,917 0 0
Gain on remeasurement of equity interest 10,495 0 0
Share of loss of equity-accounted investees (2,602) (1,124) 0
Loss before taxation (375,985) (183,391) (145,846)
Tax benefit / (provision) 1,474 (4,639) 5,559
Net loss attributable to ordinary shareholders (374,511) (188,030) (140,287)
Other comprehensive loss Items that may be reclassified subsequently to profit or loss:      
Currency translation differences (1,702) 3,579 (9,693)
Other comprehensive gain / (loss) for the year, net of income tax (1,702) 3,579 (9,693)
Total comprehensive loss for the year (376,213) (184,451) (149,980)
Loss attributable to:      
Equity holders of the parent (368,482) (186,799) (140,287)
Non-controlling interest (6,029) (1,231) 0
Net loss attributable to ordinary shareholders (374,511) (188,030) (140,287)
Total comprehensive loss attributable to:      
Comprehensive income, attributable to owners of parent (370,184) (183,220) (149,980)
Comprehensive income, attributable to non-controlling interests (6,029) (1,231) 0
Total comprehensive loss for the year $ (376,213) $ (184,451) $ (149,980)
Loss per share      
Net loss per share, Basic and Diluted (in usd per share) $ (1.36) $ (0.77) $ (0.58)
Weighted average shares outstanding, Basic and Diluted (in shares) 271,321,253 242,935,770 241,903,166
[1] Restated to reflect reclassification of certain expense items described in Note 2.